Literature DB >> 11981265

Epidemiology of anemia associated with chronic renal insufficiency.

Chi-Yuan Hsu1.   

Abstract

Several recently published reports have advanced our understanding of the epidemiology of anemia associated with chronic renal insufficiency. Anemia is commonly observed among subjects with chronic renal insufficiency. In comparison with subjects with preserved renal function, a significant decrease in hemoglobin could be detected in subjects with more modest degrees of renal insufficiency than was previously realized. Some of this undoubtedly reflects a decrease in renal production of erythropoietin, but these subjects may also suffer concomitant 'anemia of chronic disease'. Anemia is more likely not only among those with worse renal insufficiency, but also among black subjects, those with relative iron deficiency and those with lower serum albumin. Compared with those with preserved renal function, a significant decrease in hemoglobin could be detected in men at higher estimated creatinine clearance levels than in women; and at any given creatinine clearance, the decrease in hemoglobin is greater in men than in women. In the US, 800000 adults were estimated to suffer chronic renal insufficiency associated anemia, defined as hemoglobin level below 11 g/dl. As detailed in the present review, several methodological issues should be kept in mind when interpreting the literature. Further studies are needed to define the clinical implications of this common condition and to determine the most appropriate therapeutic response.

Entities:  

Mesh:

Year:  2002        PMID: 11981265     DOI: 10.1097/00041552-200205000-00011

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  8 in total

Review 1.  Effect of daprodustat on anemia in patients with chronic kidney disease: a meta-analysis.

Authors:  Dengpiao Xie; Jianting Wang; Xinping Wu; Mingquan Li
Journal:  Int Urol Nephrol       Date:  2018-08-02       Impact factor: 2.370

2.  Evaluation of ischemia-modified albumin in anemia associated to chronic kidney disease.

Authors:  Luiz Carlos Cichota; Rafael Noal Moresco; Marta Maria Medeiros Frescura Duarte; José Edson Paz da Silva
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

3.  C.E.R.A. corrects anemia in patients with chronic kidney disease not on dialysis: results of a randomized clinical trial.

Authors:  Iain C Macdougall; Rowan Walker; Robert Provenzano; Fernando de Alvaro; Harold R Locay; Paul C Nader; Francesco Locatelli; Frank C Dougherty; Ulrich Beyer
Journal:  Clin J Am Soc Nephrol       Date:  2008-02-20       Impact factor: 8.237

4.  The Impact of Renin-Angiotensin System Blockade on Renal Outcomes and Mortality in Pre-Dialysis Patients with Advanced Chronic Kidney Disease.

Authors:  Yun Jung Oh; Sun Moon Kim; Byung Chul Shin; Hyun Lee Kim; Jong Hoon Chung; Ae Jin Kim; Han Ro; Jae Hyun Chang; Hyun Hee Lee; Wookyung Chung; Chungsik Lee; Ji Yong Jung
Journal:  PLoS One       Date:  2017-01-25       Impact factor: 3.240

5.  Relative Incidence of Acute Adverse Events with Ferumoxytol Compared to Other Intravenous Iron Compounds: A Matched Cohort Study.

Authors:  James B Wetmore; Eric D Weinhandl; Jincheng Zhou; David T Gilbertson
Journal:  PLoS One       Date:  2017-01-30       Impact factor: 3.240

6.  Toward confirmation of the safety and efficacy of methoxy polyethylene glycol-epoetin beta in anemia treatment in patients on hemodialysis: a Macedonian experience.

Authors:  Isidora Kacarska-Fotevska; Nadja Volckova; Katerina Ilievska; Doncho Donev
Journal:  Croat Med J       Date:  2019-10-31       Impact factor: 1.351

7.  The efficacy and safety of roxadustat for the treatment of anemia in non-dialysis dependent chronic kidney disease patients: An updated systematic review and meta-analysis of randomized clinical trials.

Authors:  Basel Abdelazeem; Joseph Shehata; Kirellos Said Abbas; Nahla Ahmed El-Shahat; Bilal Malik; Pramod Savarapu; Mostafa Eltobgy; Arvind Kunadi
Journal:  PLoS One       Date:  2022-04-01       Impact factor: 3.240

8.  The Cost-Effectiveness of Continuous Erythropoiesis Receptor Activator Once Monthly versus Epoetin Thrice Weekly for Anaemia Management in Chronic Haemodialysis Patients.

Authors:  Omar Maoujoud; Samir Ahid; Hocein Dkhissi; Zouhair Oualim; Yahia Cherrah
Journal:  Anemia       Date:  2015-12-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.